%%tb-image-alt-text%%

COPD – FLASH STUDY – Multi-centre

Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 40 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

CHRONIC PAIN – Survey Assessment

people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

COPD – FLASH Study

 If you answered yes to these questions, you may be able to take part in a new research study.   Our Research Centre in Drummoyne is participating in the study. …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

%%tb-image-alt-text%%

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

ODYSSEY – Type 2 Diabetes and High Cholesterol

We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting